Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

University of Toronto

$164,196.00

Refining processes to maximize the provision of donor human milk rich in nutrients and bioactive components: An_x000d_ integrated multidisciplinary approach at a human milk bank serving critically-ill neona

FY 2020-21

Summary
Infant formulas attempt to mimic the nutrient composition of human breastmilk, but cannot provide its bioactive factors. These factors enhance immune function, and optimum growth and development of the newborn. Human milk is also the best health promoter for preterm babies (approximately 10 % of the 350,000 children born annually in Canada), who are often ill and may require extended hospitalization. However, preterm babies may be separated from their mothers while hospitalized, or mothers may not be able to produce an adequate milk supply due to their own illness and/or stress associated with preterm delivery. The Rogers Hixon Ontario Human Milk Bank (OMB) dispenses, by prescription, milk from approved donor mothers to these ill newborns. At the OMB, donated milk undergoes thermal pasteurization (heating at 62.5°C for 30 min). This heat treatment has two fundamental problems: 1) nutrient composition is affected and human milk bioactive molecules may be inactivated, and 2) Bacillus cereus, a spore-forming bacterium, can resist pasteurization. Because current methods cannot differentiate between pathogenic and non-pathogenic B. cereus, the OMB must discard 15-30% of their milk supply. We have formed a multidisciplinary team that will tackle these two problems simultaneously. Firstly, by adopting a non-thermal pasteurization method known as high hydrostatic pressure pasteurization (HHPP), we hypothesize that we will be able to preserve milk nutrients and biologically active molecules. Consequently, the OMB will be able to dispense donor milk that can fully exert its multiple beneficial biological/immunological functions, improving health outcomes for vulnerable infants. Secondly, we will leverage HHPP to further reduce B. cereus contamination, and create and deploy genome-based bioinformatics means to differentiate between non-pathogenic and pathogenic B. cereus. As a result, our research will help reduce milk losses, and permit the OMB to serve more preterm newborns.
Program
Collaborative Health Research Projects
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
538809-2019
Name nom
Fittipaldi, Nahuel
Department département
Cell and Systems Biology (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2019
Award amount
164196
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Installment
inst:2 - 3
Partie
2
Nb partie
3
Application title
Refining processes to maximize the provision of donor human milk rich in nutrients and bioactive components: An_x000d_ integrated multidisciplinary approach at a human milk bank serving critically-ill neona
Keyword
NSERC
Application summary
Infant formulas attempt to mimic the nutrient composition of human breastmilk, but cannot provide its bioactive factors. These factors enhance immune function, and optimum growth and development of the newborn. Human milk is also the best health promoter for preterm babies (approximately 10 % of the 350,000 children born annually in Canada), who are often ill and may require extended hospitalization. However, preterm babies may be separated from their mothers while hospitalized, or mothers may not be able to produce an adequate milk supply due to their own illness and/or stress associated with preterm delivery. The Rogers Hixon Ontario Human Milk Bank (OMB) dispenses, by prescription, milk from approved donor mothers to these ill newborns. At the OMB, donated milk undergoes thermal pasteurization (heating at 62.5°C for 30 min). This heat treatment has two fundamental problems: 1) nutrient composition is affected and human milk bioactive molecules may be inactivated, and 2) Bacillus cereus, a spore-forming bacterium, can resist pasteurization. Because current methods cannot differentiate between pathogenic and non-pathogenic B. cereus, the OMB must discard 15-30% of their milk supply. We have formed a multidisciplinary team that will tackle these two problems simultaneously. Firstly, by adopting a non-thermal pasteurization method known as high hydrostatic pressure pasteurization (HHPP), we hypothesize that we will be able to preserve milk nutrients and biologically active molecules. Consequently, the OMB will be able to dispense donor milk that can fully exert its multiple beneficial biological/immunological functions, improving health outcomes for vulnerable infants. Secondly, we will leverage HHPP to further reduce B. cereus contamination, and create and deploy genome-based bioinformatics means to differentiate between non-pathogenic and pathogenic B. cereus. As a result, our research will help reduce milk losses, and permit the OMB to serve more preterm newborns.
University of Toronto - $164,196 Grant (2020-21) | Canada Spends